Associate Members

Associate Members are investigators who work closely with one or more Center members and who have major responsibility for design, conduct, and reporting of research studies, but who have not yet reached independence in funding; and individuals who contribute greatly on an ongoing basis to research projects at Center for Neurobiology of Stress. They are reviewed periodically for advancement to full membership.

If you are interested in becoming an Associate Member, please contact Million Mulugeta, DVM, PhD at mmuluget@ucla.edu.

Associate Members are listed in alphabetical order.


A B C E F G H I J K L M N P R S T V W Y Z

K

Photo of Sahib Khalsa, MD, PhD

Sahib Khalsa, MD, PhD

Dr. Khalsa received a B.S. in Psychology from SUNY Stony Brook in 2002. He graduated from the Medical Scientist Training Program at the University of Iowa, receiving M.D. and Ph.D. (neuroscience) degrees in 2009. He completed his residency training in Psychiatry at UCLA in 2013, serving as the program Chief Resident and Chief Resident in the UCLA Anxiety Disorders Clinic.…Read More

Dr. Khalsa received a B.S. in Psychology from SUNY Stony Brook in 2002. He graduated from the Medical Scientist Training Program at the University of Iowa, receiving M.D. and Ph.D. (neuroscience) degrees in 2009. He completed his residency training in Psychiatry at UCLA in 2013, serving as the program Chief Resident and Chief Resident in the UCLA Anxiety Disorders Clinic. At that time, he joined the department as a faculty member in the Division of Adult Psychiatry at UCLA, becoming an Assistant Professor in Residence in 2014.

Dr. Khalsa’s research examines how people feel their heartbeat, how the human brain maps cardiac sensation, and whether there is dysfunctional cross talk between the heart and brain in psychiatric and cardiovascular illnesses. To approach these questions, his studies have examined the effects of aging, focal brain injury, cardiac dysfunction, and long-term meditation practice on awareness of the heartbeat. Ongoing projects examine the neural basis of cardiac sensation, the neural basis of dysfunctional heart-brain communication in anorexia nervosa, and the impact of implantable cardioverter defibrillators (ICD) on awareness of the heartbeat. These studies aim to ultimately answer the question “How can we develop new treatments that re-establish a functional dialogue between the heart and brain?”

Dr. Khalsa’s clinical expertise focuses on the assessment and treatment of anxiety disorders. As a faculty member Dr. Khalsa served as Associate Director of the UCLA Anxiety Disorders Clinic, supervising resident physicians in the treatment of anxiety disorders. As founding Director of the Healthy Hearts Behavioral Medicine Program, an interdisciplinary endeavor started with the UCLA Cardiac Arrhythmia Center, he specializes in treating anxiety and mood disorders in individuals with cardiovascular disease and who have received ICDs. He also worked as an attending psychiatrist in the UCLA OCD Intensive Outpatient Program.

In February 2015, Dr. Khalsa joined the Laureate Institute for Brain Research in Tulsa, Oklahoma, as the Director of Clinical Studies, and as an Assistant Professor (tenure track) on the Faculty of Community Medicine at the University of Tulsa.

Photo of Hon Wai Koon, PhD

Hon Wai Koon, PhD

Dr. Koon’s research is focused on the roles of antimicrobial peptide Cathelicidin in inflammatory bowel disease, intestinal infection and colon cancer. Cathelicidin is a natural endogenous anti-microbial peptide that is protective to host as a part of innate immune system. Dr. Koon’s laboratory was the first to show the anti-inflammatory effects of cathelicidin in C. difficile infection in mice and C.…Read More

Dr. Koon’s research is focused on the roles of antimicrobial peptide Cathelicidin in inflammatory bowel disease, intestinal infection and colon cancer. Cathelicidin is a natural endogenous anti-microbial peptide that is protective to host as a part of innate immune system. Dr. Koon’s laboratory was the first to show the anti-inflammatory effects of cathelicidin in C. difficile infection in mice and C. difficile toxin A and B in monocytes and macrophages. Cathelicidin mediates various anti-inflammatory signaling pathways that promote healing of intestinal mucosa. Such anti-inflammatory effects of cathelicidin may be protective to other acute and chronic intestinal inflammation. This involves the coordination of epithelial, endothelial and immune systems in intestine and establishes a new direction of research in digestive diseases across various functional systems in body.

Dr. Koon is also interested in the correlation of gene expression of cathelicidin and other antimicrobial compounds with the development of inflammatory bowel disease and other intestinal diseases.

Dr. Koon received Master and PhD degrees at the University of Hong Kong. He then completed his postdoctoral training in basic gastroenterology research at the Beth Israel Deaconess Medical Center of Harvard Medical School in Boston. He is Assistant Professor of UCLA Division of Digestive Diseases as well as a member of UCLA IBD Center and American Gastroenterological Association. Dr. Koon has a team of 3 undergraduate research project students, 1 postdoctoral fellow and 1 medical resident researcher. Dr. Koon’s projects are currently funded by NIH and CCFA grants.